Jamil Khurram
Chief Medical Officer
Jamil Khurram has filed 8 SEC Form 4 filings (30 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Jul 16, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| GALT | Chief Medical Officer | Sale | 16,250 | $83K | Jul 16 | SEC ↗ | |
| GALT | Chief Medical Officer | Sale | 4,570 | $23K | Jun 30 | SEC ↗ | |
| GALT | Chief Medical Officer | Sale | 47,467 | $239K | Jun 30 | SEC ↗ | |
| GALT | Chief Medical Officer | Sale | 7,557 | $24K | Jun 25 | SEC ↗ | |
| GALT | Chief Medical Officer | Sale | 568 | $2K | May 28 | SEC ↗ | |
| GALT | Chief Medical Officer | Sale | 13,055 | $55K | Jan 6 | SEC ↗ | |
| GALT | Chief Medical Officer | Sale | 25,499 | $99K | Jan 6 | SEC ↗ | |
| GALT | Chief Medical Officer | Sale | 21,446 | $78K | Jan 6 | SEC ↗ | |
| GALT | Chief Medical Officer | Sale | 8,125 | $33K | Jan 5 | SEC ↗ | |
| GALT | Chief Medical Officer | Sale | 19,442 | $137K | Dec 19 | SEC ↗ | |
| GALT | Chief Medical Officer | Sale | 79,617 | $436K | Nov 14 | SEC ↗ |